CN111247162A - 多黏菌素类似物及其制备方法 - Google Patents

多黏菌素类似物及其制备方法 Download PDF

Info

Publication number
CN111247162A
CN111247162A CN201880070045.2A CN201880070045A CN111247162A CN 111247162 A CN111247162 A CN 111247162A CN 201880070045 A CN201880070045 A CN 201880070045A CN 111247162 A CN111247162 A CN 111247162A
Authority
CN
China
Prior art keywords
dab
leu
ala
deletion
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201880070045.2A
Other languages
English (en)
Other versions
CN111247162B (zh
Inventor
冯军
张喜全
路建光
东圆珍
张友
唐汉卿
徐宏江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry, Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Shanghai Institute of Pharmaceutical Industry
Publication of CN111247162A publication Critical patent/CN111247162A/zh
Application granted granted Critical
Publication of CN111247162B publication Critical patent/CN111247162B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明属于医药领域,涉及具有高抗菌活性的多黏菌素类似物及其制备方法与应用,本发明的多黏菌素类似物对耐药细菌、真菌具有广谱、高效的杀菌效果。

Description

PCT国内申请,说明书已公开。

Claims (15)

  1. PCT国内申请,权利要求书已公开。
CN201880070045.2A 2017-10-31 2018-10-31 多黏菌素类似物及其制备方法 Active CN111247162B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201711043181 2017-10-31
CN2017110431816 2017-10-31
PCT/CN2018/112889 WO2019085926A1 (zh) 2017-10-31 2018-10-31 多黏菌素类似物及其制备方法

Publications (2)

Publication Number Publication Date
CN111247162A true CN111247162A (zh) 2020-06-05
CN111247162B CN111247162B (zh) 2022-02-18

Family

ID=66332842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880070045.2A Active CN111247162B (zh) 2017-10-31 2018-10-31 多黏菌素类似物及其制备方法

Country Status (2)

Country Link
CN (1) CN111247162B (zh)
WO (1) WO2019085926A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110669107A (zh) * 2018-07-02 2020-01-10 上海医药工业研究院 抗菌肽及其制备方法
CN113248572A (zh) * 2021-04-30 2021-08-13 重庆理工大学 一种抗多重耐药菌环肽及其应用

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055543A2 (en) * 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
US20090081733A1 (en) * 2007-07-20 2009-03-26 Joy Doran-Peterson Methods for producing and using polymyxins
WO2009139635A1 (en) * 2008-05-15 2009-11-19 Prosensa Technologies B.V. Polymyxin derivatives and uses thereof
CN101851270A (zh) * 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
CN101970461A (zh) * 2008-02-08 2011-02-09 北方抗生素有限公司 短链脂肪酸尾多粘菌素衍生物及其用途
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
EP2679301A1 (de) * 2012-06-28 2014-01-01 Zentrum für biomedizinische Technologie der Donau- Universität Krems Extrakorporale Perfusionsvorrichtung
US20140162937A1 (en) * 2008-02-08 2014-06-12 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
CN105308065A (zh) * 2013-05-22 2016-02-03 新药物许可控股有限公司 多粘菌素衍生物及其在与不同抗生素的组合疗法中的用途
EP3173421A1 (en) * 2015-11-30 2017-05-31 Universitat de Barcelona Peptidic compounds useful as antibacterial agents

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055543A2 (en) * 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
US20090081733A1 (en) * 2007-07-20 2009-03-26 Joy Doran-Peterson Methods for producing and using polymyxins
CN101970461A (zh) * 2008-02-08 2011-02-09 北方抗生素有限公司 短链脂肪酸尾多粘菌素衍生物及其用途
US20140162937A1 (en) * 2008-02-08 2014-06-12 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
WO2009139635A1 (en) * 2008-05-15 2009-11-19 Prosensa Technologies B.V. Polymyxin derivatives and uses thereof
CN101851270A (zh) * 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
EP2679301A1 (de) * 2012-06-28 2014-01-01 Zentrum für biomedizinische Technologie der Donau- Universität Krems Extrakorporale Perfusionsvorrichtung
CN105308065A (zh) * 2013-05-22 2016-02-03 新药物许可控股有限公司 多粘菌素衍生物及其在与不同抗生素的组合疗法中的用途
EP3173421A1 (en) * 2015-11-30 2017-05-31 Universitat de Barcelona Peptidic compounds useful as antibacterial agents

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KARIM NAGHMOUCHI ET AL: "Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli", 《RES MICROBIOL》 *
TRIMBLE MJ ET AL: "Polymyxin: Alternative Mechanisms of Action and Resistance.", 《COLD SPRING HARBOR PERSPECTIVES IN MEDICINE》 *
周忠新等: "治疗多药耐药革兰阴性细菌感染的一线药物—多黏菌素的复兴", 《国外医药(抗生素分册)》 *
邝俊健等: "多黏菌素的研究进展与用药安全性", 《中国执业药师》 *
马骏等: "多重耐药的严峻形势下多黏菌素E临床应用进展", 《中华临床医师杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110669107A (zh) * 2018-07-02 2020-01-10 上海医药工业研究院 抗菌肽及其制备方法
CN110669107B (zh) * 2018-07-02 2024-04-02 上海医药工业研究院 抗菌肽及其制备方法
CN113248572A (zh) * 2021-04-30 2021-08-13 重庆理工大学 一种抗多重耐药菌环肽及其应用

Also Published As

Publication number Publication date
CN111247162B (zh) 2022-02-18
WO2019085926A1 (zh) 2019-05-09

Similar Documents

Publication Publication Date Title
Tamamura et al. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity
KR101306643B1 (ko) 항미생물성 헥사펩티드
US11046730B2 (en) Antimicrobial compositions
EP1614691B1 (en) Antibacterial peptide
CN106414480A (zh) 作为抗微生物化合物的多黏菌素衍生物
KR20090051041A (ko) 암과 같은 변경된 세포 이동과 연관된 질환을 치료하기 위한 약리학적 활성을 갖는 펩티드
US20190315806A1 (en) Polymyxin derivative, preparation method and application thereof
EP2575851B1 (en) Novel anticancer agents comprising peptides with cancer-specific toxicity
CN111247162B (zh) 多黏菌素类似物及其制备方法
CN102766196B (zh) 一组阳离子抗菌肽及其制备方法和应用
CN114790226A (zh) 一种抗菌肽及其制备方法
WO2005023846A1 (en) New antitumoral compounds
AU2021200731B2 (en) Pro-drug peptide with improved pharmaceutical properties
CN105837675A (zh) 一组阳离子抗菌肽及其制备方法
CN110669107B (zh) 抗菌肽及其制备方法
CN113121627A (zh) 两性霉素b甲酯肽衍生物及其制备方法
CA2405724C (en) Substance p analogs for the treatment of cancer
WO2020119773A1 (zh) 两性霉素b肽衍生物
US6596692B1 (en) Substance P analogs for the treatment of cancer
WO2020159389A1 (en) Compounds of vancomycin and tp10, methods of their preparation, composition and use in antibacterial treatment
AU671118B2 (en) Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
CN112300250B (zh) 阿尼芬净类似物及其制备方法
WO2023034481A1 (en) Peptides with antimicrobial activities
WO2020117081A1 (en) Peptides for use in prevention and treatment of inflammation
WO2000078793A2 (en) Antimicrobial agents

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant